National Study for Prevention of Embolism in Atrial Fibrillation "NASPEAF"

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Patients with chronic or documented atrial fibrillation (AF) attack.

Exclusion Criteria

Patients at low risk according to Stroke Prevention in Atrial Fibrillation (SPAF) III stratification (7). Patients were also excluded by mechanical valve prosthesis, stroke in the previous six months, serum creatinine over 3 mg/dl, alcoholism or drug addiction, severe uncontrolled hypertension, diffuse arteriosclerosis, and indication for non-steroidal anti-inflammatory drugs or indication/contraindication for antiplatelet or anticoagulant therapy.